WeChat Mini Program
Old Version Features

Real-World Sequential Use of CD19-Directed Therapies for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab Preceding Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Narendranath Epperla,Loretta J. Nastoupil,Bruce Feinberg,Prathamesh Pathak,Theresa Amoloja,Danielle Gentile,Kim Saverno

Hematology, Transfusion and Cell Therapy（2024）

Cited 0|Views2
Key words
ABCL,diffuse large B-cell lymphoma,immunotherapy,real-world,tafasitamab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined